{
    "clinical_study": {
        "@rank": "45352", 
        "acronym": "DIALOGUE5", 
        "arm_group": [
            {
                "arm_group_label": "Molidustat (BAY85-3934)", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Epoetin alfa/beta", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate efficacy and safety up to 36 months of titrated dose treatment with BAY85-3934\n      versus epoetin alfa/beta. Titration will be based on the subject's hemoglobin (Hb) response\n      and tolerability of the prior dose. Planned doses include 15, 25, 50, 75, 100,and 150 mg\n      once daily."
        }, 
        "brief_title": "Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934", 
        "completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Anemia", 
            "Renal Insufficiency, Chronic"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Kidney Diseases", 
                "Renal Insufficiency", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Eligible male or female subjects were previously enrolled in Study 16208, have a\n             diagnosis of anemia associated with CKD, and are on hemodialysis.\n\n          -  Men who agree to use adequate contraception when sexually active or women without\n             childbearing potential\n\n          -  Participation and completion of treatment in Study 16208; subjects must have received\n             16 weeks of study medication and completed the end of treatment visit (Day 113) in\n             the parent study\n\n          -  Mean Hb concentration of 9.5 to 11.5 g/dL, inclusive, during the evaluation period\n             (i.e., the last 4 weeks of the parent study) when the subject completed 16 weeks of\n             treatment with BAY85-3934, epoetin alfa, or epoetin beta in Study 16208\n\n        Exclusion Criteria:\n\n          -  A scheduled kidney transplant or any other organ transplant within the next 6 months\n             (being on a waiting list does not exclude the subject)\n\n          -  Updates to medical and surgical history which meet the exclusion criteria in the\n             parent study\n\n          -  Subjects treated with immunosuppressive therapy and the breast cancer resistant\n             protein (BCRP) substrates, irinotecan, topotecan, methotrexate, imatinib, and\n             lapatinib\n\n          -  Sustained, poorly controlled arterial hypertension or hypotension at baseline,\n             defined as mean BP \u2265 180/110 mmHg or systolic BP < 95 mmHg, respectively\n\n          -  Severe rhythm or conduction disorder (e.g., HR < 50 or > 110 bpm, atrial fibrillation\n             or flutter, prolonged QT > 500 msec, second or third degree atrioventricular [AV]\n             block)\n\n          -  New York Heart Association Class III or IV congestive heart failure\n\n          -  Severe hepatic insufficiency (defined as alanine aminotransferase [ALT], aspartate\n             aminotransferase [AST], or gamma-glutamyl transferase > 3 x the upper limit of norma\n             [ULN], total bilirubin > 2 mg/dL, or Child-Pugh B or C) or active hepatitis in the\n             investigator's opinion\n\n          -  An ongoing SAE from Study 16208 that is assessed as related to study drug\n\n          -  Alcohol or drug abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "148", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02064426", 
            "org_study_id": "16209"
        }, 
        "intervention": [
            {
                "arm_group_label": "Molidustat (BAY85-3934)", 
                "description": "Subjects will continue with the same treatment they were receiving in the parent study (16208). BAY85-3934 will be administered daily as oral tablets. Dose assessments will be made every 4 (\u00b1 1) weeks. At the scheduled visits, the dose may be titrated on an individualized basis taking into account the subject's Hb response and the tolerability of the previous dose. Total treatment time is up to 36 months. Planned doses include 15, 25, 50, 75, 100, and 150 mg once daily.", 
                "intervention_name": "Molidustat (BAY85-3934)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Epoetin alfa/beta", 
                "description": "Subjects will continue with the same treatment they were receiving in the parent study (16208). Epoetin alfa / beta will be administered as intravenous (IV) or subcutaneous (SC) injections per individual subject regimen according to the local label. Dose assessments will be made every 4 (\u00b1 1) weeks. At the scheduled visits,dose may be titrated on an individualized basis taking into account the subject's Hb response and the tolerability of the previous dose.Total treatment time is up to 36 months.", 
                "intervention_name": "Epoetin alfa/beta", 
                "intervention_type": "Biological"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Epoetin Alfa"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Anemia of CKD on dialysis", 
        "lastchanged_date": "May 15, 2014", 
        "link": [
            {
                "description": "Click here and search for drug information provided by the FDA.", 
                "url": "http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm"
            }, 
            {
                "description": "Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.", 
                "url": "http://www.fda.gov/medwatch/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Tempe", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85284"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Azusa", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91702"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90025"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Northridge", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91324"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Dimas", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91773"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Whittier", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90602"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Port Richey", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34652"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eatontown", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07724"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brooklyn", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11212"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14215"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fresh Meadows", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11365"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45206"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toledo", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43615"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37212-8150"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Worth", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76164"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Worth", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76105"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Worth", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76104"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77091"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78215"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muroran", 
                        "country": "Japan", 
                        "state": "Hokkaido", 
                        "zip": "050-0083"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Himeji", 
                        "country": "Japan", 
                        "state": "Hyogo", 
                        "zip": "670-0947"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kuwana", 
                        "country": "Japan", 
                        "state": "Mie", 
                        "zip": "511-0061"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kanagawa", 
                        "country": "Japan", 
                        "zip": "210-0024"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kyoto", 
                        "country": "Japan", 
                        "zip": "607-8116"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagano", 
                        "country": "Japan", 
                        "zip": "388-8004"
                    }
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Japan"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Controlled, Parallel Group, Open-label, Multicenter Extension Study to Investigate Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Long-term Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis in the United States and Japan", 
        "overall_contact": {
            "email": "clinical-trials-contact@bayerhealthcare.com", 
            "last_name": "Bayer Clinical Trials Contact"
        }, 
        "overall_contact_backup": {
            "last_name": "For trial location information (Phone Menu Options '3' or '4')", 
            "phone": "(+)1-888-84 22397"
        }, 
        "overall_official": {
            "affiliation": "Bayer", 
            "last_name": "Bayer Study Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Japan: Ministry of Health Labour and Healthcare", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in local laboratory hemoglobin level from baseline", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 36 months"
            }, 
            {
                "measure": "Number of participants with serious adverse events as a measure of safety and tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 36 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02064426"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Maintenance in hemoglobin target range (10.0 to 11.0 g/dL)", 
                "safety_issue": "No", 
                "time_frame": "Up to 36 months"
            }, 
            {
                "measure": "Maintenance in hemoglobin target range (9.5 to 11.5 g/dL)", 
                "safety_issue": "No", 
                "time_frame": "Up to 36 months"
            }, 
            {
                "measure": "Duration of treatment exposure", 
                "safety_issue": "No", 
                "time_frame": "Up to 36 months"
            }, 
            {
                "measure": "Number of subjects requiring titration of dose", 
                "safety_issue": "No", 
                "time_frame": "Up to 36 months"
            }, 
            {
                "measure": "Change of reticulocyte count from baseline of this study", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 36 months"
            }, 
            {
                "measure": "Change of reticulocyte count from baseline of study 16208", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 36 months"
            }, 
            {
                "measure": "Change of red blood cell count from baseline of this study", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 36 months"
            }, 
            {
                "measure": "Change of red blood cell count from baseline of study 16208", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 36 months"
            }, 
            {
                "measure": "Change of hematocrit from baseline of this study", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 36 months"
            }, 
            {
                "measure": "Change of hematocrit from baseline of study 16208", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 36 months"
            }, 
            {
                "measure": "Change of central laboratory hemoglobin level from baseline of this study", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 36 months"
            }, 
            {
                "measure": "Change of central laboratory hemoglobin level from baseline of study 16208", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 36 months"
            }
        ], 
        "source": "Bayer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bayer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}